|
|
|
|
|
|
by kamens
1214 days ago
|
|
|
I'm not so confident on this bias claim. Biasing high would be an extremely risky decision for a glucose monitoring company, because it encourages insulin dosing which could be deadly. Biasing low would be the move if scared of risky downsides. |
|
|